← Oncology Approval Tracker

FDA DECISION ·

Bendamustine Hydrochloride Injection (Hospira)

bendamustine hydrochloride · Hospira

FDA approvalNew formulationChronic lymphocytic leukemia and indolent B-cell lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Bendamustine injection for adults with CLL or indolent B-cell NHL progressing during or within six months after rituximab-containing therapy.

LAMPGEN ANALYSIS

Why it matters

This FDA action authorizes a separate injection product for established bendamustine uses.

What research teams should watch

Check the product-specific concentration, dilution and infusion instructions when ordering or stocking this presentation.

PRIMARY RECORDS

Sources